Literature DB >> 3779211

Antiarrhythmic effects of DPI 201-106.

G Scholtysik, F M Williams.   

Abstract

The cardiotonic agent DPI 201-106 (4-[3-(4-diphenylmethyl-1-piperazinyl-2- hydroxypropyl]-1H-indole-2-carbonitrile) which modifies the sarcolemmal Na+ channel gating system and has electrophysiological properties of class III antiarrhythmics was investigated for local anaesthetic and antiarrhythmic activity. The compound action potential amplitude of cat cervical vagus nerves in vitro was decreased by DPI 201-106 in a concentration-dependent manner, the IC50 being 1.82 X 10(-5) M. This was paralleled by a slowing in conduction velocity and demonstrates local anaesthetic effects. Ventricular fibrillation which occurs in response to coronary artery reperfusion in rats was prevented by intravenous infusions of 0.3 mg kg-1 min-1 of DPI 201-106. The arrhythmogenic intravenous doses of aconitine in rats were increased following pretreatment with DPI 201-106 in a dose-dependent manner. DPI 201-106 did not protect against ouabain-induced arrhythmias in guinea-pigs. The results demonstrate that DPI 201-106 has local anaesthetic effects and is a potential antiarrhythmic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779211      PMCID: PMC1917020          DOI: 10.1111/j.1476-5381.1986.tb10258.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Modification of single cardiac Na+ channels by DPI 201-106.

Authors:  M Kohlhardt; U Fröbe; J W Herzig
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

Review 2.  Classification of antidysrhythmic drugs.

Authors:  E M Vaughan Williams
Journal:  Pharmacol Ther B       Date:  1975

3.  Action of prilocaine on the vagus nerve and on adrenaline induced extrasystole in dogs.

Authors:  A Nava-Rivera; A Gutiérrez-López; A Férez; W Eisenberg
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-10

Review 4.  Digitalis.

Authors:  K O Haustein
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

Review 5.  Drugs with a class III antiarrhythmic action.

Authors:  R S Bexton; A J Camm
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

6.  The depolarizing action of 5-HT on mammalian non-myelinated nerve fibres.

Authors:  F Riccioppo Neto
Journal:  Eur J Pharmacol       Date:  1978-06-15       Impact factor: 4.432

7.  The mode of antiarrhythmic action of melperone.

Authors:  E S Platou; H Refsum; E S Myhre; J P Amlie; K Landmark
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-02

Review 8.  Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade.

Authors:  L H Opie; W F Lubbe
Journal:  S Afr Med J       Date:  1979-11-24

9.  Myocardial concentration of norepinephrine and cyclic AMP in ventricular fibrillation during acute myocardial ischemia.

Authors:  H Kanayama; M Ban; K Ogawa; T Satake
Journal:  J Cardiovasc Pharmacol       Date:  1982 Nov-Dec       Impact factor: 3.105

10.  How increased sodium influx enhances digoxin-induced arrhythmias in guinea-pig atrial muscle.

Authors:  R H Kennedy; T Akera; T M Brody
Journal:  Eur J Pharmacol       Date:  1983-05-06       Impact factor: 4.432

View more
  6 in total

1.  Inhibition of the sodium pump by cardioactive DPI 201-106.

Authors:  A J Kaumann; D E Richards; D A Russell
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

2.  Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.

Authors:  B I Armah; T Pfeifer; U Ravens
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

3.  The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.

Authors:  Sung-Han Hsiao; Megumi Murakami; Ni Yeh; Yan-Qing Li; Tai-Ho Hung; Yu-Shan Wu; Suresh V Ambudkar; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2018-07-18       Impact factor: 8.679

4.  Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.

Authors:  T Ozaki; T Uematsu; S Nagashima; M Nishimoto; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

5.  Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.

Authors:  D Baumgart; T Ehring; M Krajcar; A Skyschally; G Heusch
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

6.  Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.

Authors:  P K Siegl; M L Garcia; V F King; A L Scott; G Morgan; G J Kaczorowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.